Entre las marcas de nuestros más de 25 colaboradores destaca TargetMol
We have reached an agreement with TargetMol: CymitQuimica clients will benefit for a 20% discount on all TargetMol products until the end of the year.On our website you can find the products offered by this partner, which has become one of the world's most recognised compound libraries and small molecule inhibitors supplier. TargetMol offers approximately 120 compound libraries and a wide range of chemical products and kits for life sciences.
Termina el 31 dic( quedan 8 días )
Justicidin B
CAS:Justicidin B: anticancer, proapoptotic, inhibits bone resorption & platelets, antiviral, fungicidal, antiprotozoal.Fórmula:C21H16O6Forma y color:SolidPeso molecular:364.35D-threo-PDMP
CAS:D-threo-PDMP inhibits glucoceramide synthase, cutting cell surface glycosphingolipids and hindering neurite growth.Fórmula:C23H38N2O3Forma y color:SolidPeso molecular:390.56JNJ-49095397
CAS:<p>JNJ-49095397 (RV568) is a p38 MAPK-α and p38 MAPK-γ kinase inhibitor for the study of respiratory syncytial virus infection.</p>Fórmula:C34H36N6O4Pureza:98.33% - 99.04%Forma y color:SolidPeso molecular:592.69PKCiota-IN-1
CAS:<p>PKCiota-IN-1: Strong PKC-ι inhibitor (IC50=2.7 nM); also blocks PKC-α/ε (IC50s=45/450 nM).</p>Fórmula:C25H22FN5OForma y color:SolidPeso molecular:427.47FITM
CAS:FITM is a potent negative allosteric modulator of mGlu1 receptor(Ki : 2.5 nM).Fórmula:C18H18FN5OSPureza:97.25%Forma y color:SolidPeso molecular:371.43Azaphilone-9
CAS:<p>AZA-9 inhibits cancer growth by blocking HuR-ARE RNA binding; IC50=1.2μM.</p>Fórmula:C21H23BrO5Forma y color:SolidPeso molecular:435.31TNKS1/2-IN-1
CAS:<p>TNKS1/2-IN-1: potent inhibitor for cancer, fibrosis research; pIC50 7.1-8.2.</p>Fórmula:C26H23F4N3O4Forma y color:SolidPeso molecular:517.47VEGFR-3-IN-1
CAS:VEGFR-3-IN-1, a potent VEGFR3 inhibitor (IC50=110.4 nM), hinders tumor growth and VEGFR3 signaling, affecting HDLEC and MDA-MB cell proliferation/migration.Fórmula:C29H29ClF3N7OSPureza:99.95%Forma y color:SolidPeso molecular:616.1Naloxonazine
CAS:<p>Naloxonazine, a potent, selective opiate mu-1 (μ1) antagonist, also influences leishmania through the modulation of host coding function.</p>Fórmula:C38H42N4O6Forma y color:SolidPeso molecular:650.76IMD-vanillin
CAS:IMD-vanillin is a novel compound characterized as an imidazoquinolinone-derived dimer with NF-κB immunomodulatory properties.Fórmula:C37H45N7O4Pureza:98%Forma y color:SolidPeso molecular:651.8IMD-catechol
CAS:IMD-catechol: an imidazoquinolinone-based dimer with NF-κB activity; improves CT26 cancer treatment, low toxicity.Fórmula:C31H34N6O3Pureza:98%Forma y color:SolidPeso molecular:538.64CDK4/6-IN-15
CAS:CDK4/6-IN-15: Oral, selective CDK4/6 inhibitor, halts cancer cell growth, G1 arrest, suppresses Rb phosphorylation.Fórmula:C21H27FN8SForma y color:SolidPeso molecular:442.5618:0-22:6 DG
CAS:1-Stearoyl-2-docosahexaenoyl-sn-glycerol (18:0-22:6 DG) is a diacylglycerol capable of binding to RasGRP and modulating the activation of MAP kinases.Fórmula:C43H72O5Forma y color:SolidPeso molecular:669.03EC330
CAS:EC330, a novel steroidal LIF inhibitor showed cytotoxicity in various cancer cell lines and NCI-60 cell line panel at low nano-molar range.Fórmula:C30H32F2O2Pureza:97.83%Forma y color:SolidPeso molecular:462.57NCGC00138783
NCGC00138783 blocks CD47/SIRPα interaction; IC50 of 50 µM.Fórmula:C30H28F7N7O5SForma y color:SolidPeso molecular:731.64TRK/ALK-IN-1
TRK/ALK-IN-1: Potent dual TRK & ALK inhibitor; IC50s: 2.2nM (TRKA), 9.3nM (ALK WT), 38nM (ALK L1196M); cancer research potential.Fórmula:C31H35ClF2N8O2SForma y color:SolidPeso molecular:657.18Triphen diol
CAS:Triphen diol, a phenol diol, fights pancreatic cancer & cholangiocarcinoma, inducing apoptosis via caspase-dependent & -independent paths.Fórmula:C22H20O4Forma y color:SolidPeso molecular:348.39ChemR23-IN-3
<p>ChemR23-IN-3 is a potent thiazole-based ChemR23 inhibitor with an IC 80 value of 12 nM.</p>Fórmula:C31H33N5O5S2Forma y color:SolidPeso molecular:619.75Epothilone E
CAS:<p>Epothilone E, a derivative of epothilone, functions by inhibiting microtubule protein activity, thereby halting cell division and exhibiting anti-tumor</p>Fórmula:C26H39NO7SForma y color:SolidPeso molecular:509.66Aramchol
CAS:Aramchol (C20-FABAC), a mix of arachidic & cholic acid, lessens cholesterol crystallization & dissolves crystals in bile.Fórmula:C44H79NO5Pureza:≥95%Forma y color:SolidPeso molecular:702.1eIF4A3-IN-17
CAS:<p>eIF4A3-IN-17, a silvestrol analogue, disrupts eIF4F assembly; EC50: 0.9-15 nM. Used in cancer pathogenesis research.</p>Fórmula:C28H25NO7Forma y color:SolidPeso molecular:487.5eIF4A3-IN-18
CAS:eIF4A3-IN-18, a silvestrol analogue with EC50s: 0.8/35/2 nM, inhibits eIF4F complex and is cytotoxic (LC50: 0.06 nM) for cancer research.Fórmula:C29H28N2O6Forma y color:SolidPeso molecular:500.54Palazestrant
CAS:Palazestrant, an antiestrogen and antineoplastic agent, effectively targets ER+/HER2+ cancer when used in conjunction with a HER2 inhibitor.Fórmula:C28H36FN3OPureza:97.55%Forma y color:SolidPeso molecular:449.6G4/HDAC-IN-1
<p>G4/HDAC-IN-1, a G4/HDAC dual inhibitor, IC50 1.1 µM, blocks TNBC growth, useful in cancer research.</p>Fórmula:C36H49ClFN7O4Forma y color:SolidPeso molecular:698.27JBSNF-000028
<p>JBSNF-000028: potent oral NNMT inhibitor; IC50s—human 0.033 μM, monkey 0.19 μM, mouse 0.21 μM; aids insulin sensitivity & weight loss.</p>Fórmula:C11H13N3Pureza:99.23%Forma y color:SolidPeso molecular:187.24hDHODH-IN-11
CAS:hDHODH-IN-11: potent hDHODH inhibitor, IC50 7.2 nM, low cytotoxicity, for AML research.Fórmula:C24H23N3O3Forma y color:SolidPeso molecular:401.46Miridesap
CAS:<p>Miridesap (GSK2315698) rapidly depletes SAP in blood, cerebrospinal fluid, and amyloid deposits via liver clearance.</p>Fórmula:C16H24N2O6Pureza:≥95%Forma y color:SolidPeso molecular:340.3715-PGDH-IN-1
CAS:15-PGDH-IN-1: potent oral 15-PGDH inhibitor, IC50=3nM, useful for tissue repair research.Fórmula:C24H22N4O2Forma y color:SolidPeso molecular:398.46CDK4/6-IN-14
CAS:CDK4/6-IN-14: potent CDK4/6 inhibitor, IC50s 10/16 nM, >60-fold selectivity over CDKs 1/2/7/9, selective across 205 kinases.Fórmula:C24H27ClFN7OForma y color:SolidPeso molecular:483.97Dynamin IN-1
CAS:Dynamin IN-1 is a potent dynamin inhibitor with an IC 50 value of 1.0 µM .Fórmula:C23H24N2OForma y color:SolidPeso molecular:344.45Zidesamtinib
CAS:<p>Zidesamtinib (NVL-520) is a ROS1 fusion and resistance mutation inhibitor that inhibits ROS1 and can be used to study non-small cell lung cancer.</p>Fórmula:C22H22FN7OPureza:99.74%Forma y color:SolidPeso molecular:419.455Fazamorexant
CAS:Fazamorexant (YZJ-1139) is a powerful orexin receptor antagonist effective for insomnia research.Fórmula:C25H25FN4O2Forma y color:SolidPeso molecular:432.49Gumelutamide
CAS:Gumelutamide, a tetrahydropyridopyrimidine compound, functions as both an antiandrogen and an antineoplastic agent by acting as an androgen antagonist.Fórmula:C22H21ClN6OForma y color:SolidPeso molecular:420.89Darizmetinib
CAS:Darizmetinib (HRX215) is an MKK4 inhibitor.Fórmula:C21H17F2N5O3SPureza:98.03% - 99.57%Forma y color:SolidPeso molecular:457.45DRAK1/2-IN-1
CAS:DRAK1/2-IN-1 is a potent inhibitor targeting both DRAK1 and DRAK2, displaying dissociation constants (Kd) of 1 µM and 6 µM, respectively.Fórmula:C22H24N2O3SForma y color:SolidPeso molecular:396.5BCR-ABL-IN-7
CAS:BCR-ABL-IN-7 is an inhibitor of ABL kinase activity in WT and T315I mutants.BCR-ABL-IN-7 can be used in chronic myeloid leukemia (CML) research.Fórmula:C19H16FN3O3SPureza:98.28%Forma y color:SolidPeso molecular:385.41NUCC-0000323
CAS:NUCC-0000323: potent SOD1 inhibitor, curbs expression, used in ALS research.Fórmula:C15H13BrN4SForma y color:SolidPeso molecular:361.26THZ2
CAS:THZ2 (CDK7-IN-1), an analog of THZ1, is a potent and selective CDK7 inhibitor(IC50:13.9 nM),with the potential to treat Triple-negative breast cancer (TNBC).Fórmula:C31H28ClN7O2Pureza:98.28%Forma y color:SolidPeso molecular:566.05Falcarindiol
CAS:Falcarindiol is an orally active natural polyacetylene compound, anti-inflammatory and antiproliferative. inhibits NO production, suppressing iNOS expression.Fórmula:C17H24O2Pureza:99.38%Forma y color:SolidPeso molecular:260.37Sycosterol A
<p>Sycosterol A is an α-synuclein (α-syn) inhibitory sterol .</p>Fórmula:C27H48O9SForma y color:SolidPeso molecular:548.73Anserinone B
CAS:Anserinone B: Antifungal, antibacterial; inhibits S.fimicola (50%), A. furfuraceus (37%); cytotoxic to human tumor cells (GI50=4.4 µg/mL).Fórmula:C11H14O4Forma y color:SolidPeso molecular:210.23Dictyostatin
CAS:Dictyostatin: potent microtubule stabilizer & anticancer agent with antiproliferative effects; researched for tauopathies.Fórmula:C32H52O6Forma y color:SolidPeso molecular:532.75Inuviscolide
CAS:Inuviscolide induces apoptosis, G2/M arrest in melanoma, and has anti-cancer, anti-inflammatory effects.Fórmula:C15H20O3Forma y color:SolidPeso molecular:248.32ZINC00640089
CAS:<p>ZINC00640089: Selective LCN2 inhibitor; curbs SUM149 cell growth and AKT activity; useful for IBC research.</p>Fórmula:C20H13F3N2O2Pureza:98.41% - 99.80%Forma y color:SolidPeso molecular:370.32Actinoquinol
CAS:Actinoquinol, a compound effective in absorbing UVB radiation, plays a crucial role in protecting the human eye from photooxidative and other oxidativeFórmula:C11H11NO4SForma y color:SolidPeso molecular:253.27KG-501
CAS:KG-501 (Naphthol AS-E phosphate) is a cAMP response element-binding protein (CREB) inhibitor(IC50 : 6.89 μM).Fórmula:C17H13ClNO5PPureza:97.81%Forma y color:SolidPeso molecular:377.72Rosolic Acid
CAS:Rosolic Acid activates Nrf2, boosts angiogenesis, reduces inflammation, deters apoptosis, aids pancreatic cells, and shields ECs from stress.Fórmula:C19H14O3Forma y color:SolidPeso molecular:290.31(S)-JDQ-443
CAS:<p>(S)-JDQ-443, an isomer of JDQ-443, is a selective, potent oral KRAS G12C inhibitor with antitumor properties.</p>Fórmula:C29H28ClN7OForma y color:SolidPeso molecular:526.03Octotiamine
CAS:Octotiamine (TATD), a Vitamin B1 analogue and component of the vitamin complex, is utilized in research related to Vitamin B1 deficiency.Fórmula:C23H36N4O5S3Forma y color:SolidPeso molecular:544.75Aflibercept
CAS:<p>Aflibercept has a wide range of applications in life science related research.</p>Forma y color:LiquidTGFβRI-IN-6
CAS:<p>TGFβRI-IN-6 is a potent TGFβRI inhibitor with an IC50 value of 0.55 nM.TGFβRI-IN-6 has the potential to enhance anti-tumour immunity.</p>Fórmula:C17H10F4N6Forma y color:SolidPeso molecular:374.3Cyprodenate
CAS:Cyprodenate (Actebral) is a potent orally active brain-activating agent with appetite-suppressing properties, useful in studying metabolic.Fórmula:C13H25NO2Forma y color:SolidPeso molecular:227.34c-Met-IN-16
CAS:c-Met-IN-16 is a c-Met inhibitor that can be used for cancer research .Fórmula:C21H17F2N9OForma y color:SolidPeso molecular:449.42LEM-14-1189
CAS:<p>LEM-14-1189 inhibits NSD1/2/3 (IC50: 418/111/60 μM), targets nuclear receptors, and may treat cancer and blood diseases.</p>Fórmula:C35H34N6O5S2Pureza:98.06%Forma y color:SolidPeso molecular:682.81FT011
CAS:<p>FT011, a direct anti-fibrotic agent,attenuates cardiac remodelling and dysfunction in experimental diabetic cardiomyopathy.</p>Fórmula:C20H17NO5Pureza:98.98%Forma y color:SolidPeso molecular:351.35DPNB-ABT594
DPNB-ABT594, a nitrobenzyl-caged ABT594, selectively activates α4β2 over α7 nAChRs; used to study Ca²⁺ signaling in MHb.Fórmula:C31H46ClN3O11Forma y color:SolidPeso molecular:672.16eeAChE-IN-2
CAS:eeAChE-IN-2 is a potent inhibitor of eeAChE, exhibiting inhibitory potency with an IC50 of 2 nM.Fórmula:C37H40N8O5SForma y color:SolidPeso molecular:708.83(Rac)-SHIN2
CAS:(Rac)-SHIN2 is a serine hydroxymethyltransferase (SHMT) inhibitor for the study of T-cell acute lymphoblastic leukemia (T-ALL).Fórmula:C23H26N4O3Pureza:98.165% - 99.48%Forma y color:SolidPeso molecular:406.48Masofaniten
CAS:Masofaniten (EPI-7386) is an orally active androgen receptor (AR) inhibitor with antitumor activity for the study of prostate and breast cancer.Fórmula:C24H24Cl2N4O4SPureza:98.42% - 98.66%Forma y color:SolidPeso molecular:535.44IMD-ferulic
<p>IMD-ferulic, a compound that forms covalent bonds, acts as an NF-κB modulator, enhancing the adjuvanticity of small molecule immune potentiators.</p>Fórmula:C36H41N7O4Forma y color:SolidPeso molecular:635.76photoCORM-1
photoCORM-1: a CORM with real-time CO monitoring via color change, exhibits cellular uptake and anti-tumor activity.Fórmula:C33H32Cl2N2O6Forma y color:SolidPeso molecular:623.52photoCORM-2
CAS:photoCORM-2 releases CO, changes color for real-time monitoring, has good cellular uptake, and anti-tumor properties.Fórmula:C17H13NO3Forma y color:SolidPeso molecular:279.29hGGPPS-IN-3
CAS:13h (hGGPPS-IN-3), a strong C2-ThP-BPs hGGPPS blocker, triggers MM cell apoptosis and shows in vivo anti-myeloma effects.Fórmula:C21H19BrN4O7P2SPureza:98%Forma y color:SolidPeso molecular:613.31β-Estradiol 17-acetate
CAS:<p>β-Estradiol 17-acetate (1,3,5(10)-Estratriene-3,17β-diol 17-acetate) is a metabolite of estradiol.</p>Fórmula:C20H26O3Pureza:98.11% - 99.88%Forma y color:SolidPeso molecular:314.42BAY 1214784
CAS:<p>BAY 1214784: potent, oral hGnRH-R antagonist, reduces LH levels, low variability, good tolerance, may research uterine fibroids.</p>Fórmula:C29H26ClF4N3O5S2Forma y color:SolidPeso molecular:672.11Bis-Pro-5FU
CAS:Bis-Pro-5FU enhances oral uptake and safety of 5-FU, an anti-cancer drug for colorectal and pancreatic tumors.Fórmula:C10H7FN2O2Forma y color:SolidPeso molecular:206.17Hsp90-IN-17
CAS:Hsp90-IN-17 (Example 5) is an inhibitor of HSP90, applicable in researching proliferative diseases, including cancer and neurodegenerative conditions.Fórmula:C21H20N4O7Forma y color:SolidPeso molecular:440.41HIF-2α-IN-7
CAS:HIF-2α-IN-7 is a hypoxia inducible factor 2α (HIF-2α) inhibitor.Fórmula:C18H9F6NO2Forma y color:SolidPeso molecular:385.26L-Afegostat
CAS:<p>L-Afegostat (5-epi-Isofagomine), an iminosugar, inhibits glycosidase and β-Glucosidase (K i 30 μM), aids in carbohydrate synthesis.</p>Fórmula:C6H13NO3Forma y color:SolidPeso molecular:147.17PF-06455943
CAS:PF-06455943: LRRK2 inhibitor, IC50=3nM, PET radioligand, used for ADME/neuro PK & Parkinson's research.Fórmula:C17H14FN5OForma y color:SolidPeso molecular:323.32GDC-0575
CAS:<p>GDC-0575 (ARRY-575) is a highly-selective oral small-molecule Chk1 inhibitor(IC50 of 1.2 nM).</p>Fórmula:C16H20BrN5OPureza:≥95%Forma y color:SolidPeso molecular:378.27SIRT2-IN-11
CAS:SIRT2-IN-11 (AEM1), a SIRT2 inhibitor (IC50 18.5μM), induces apoptosis and affects p53, used in cancer research.Fórmula:C21H22N2OForma y color:SolidPeso molecular:318.41eIF4A3-IN-9
CAS:eIF4A3-IN-9, a silvestrol analogue, disrupts eIF4F complex assembly; EC50s: 29/450/80 nM (myc/tub-LUC, MB-231 cells); for cancer research.Fórmula:C28H27NO8Forma y color:SolidPeso molecular:505.52METTL3-IN-1
CAS:<p>METTL3-IN-1 is a polyheterocyclic compound, acts as METTL3 inhibitor .</p>Fórmula:C25H24FN5O2Forma y color:SolidPeso molecular:445.49METTL3-IN-2
CAS:METTL3-IN-2, a potent METTL3 inhibitor, exhibits an IC50 value of 6.1 nM, effectively impairing the proliferation of Caov3 cancer cells.Fórmula:C25H26N8OForma y color:SolidPeso molecular:454.53METTL3-IN-3
CAS:METTL3-IN-3 is a polyheterocyclic compound, acts as METTL3 inhibitor .Fórmula:C26H28BrFN6O2Forma y color:SolidPeso molecular:555.44PF-07054894
CAS:PF-07054894: potent CCR6 antagonist, targets GPCR, for inflammatory bowel disease research.Fórmula:C24H30N6O4Forma y color:SolidPeso molecular:466.53cis-ccc_R08
CAS:cis-ccc_R08 infection . cis-ccc_R08 is a cccDNA (covalently closed circular DNA) inhibitor .Fórmula:C22H19ClO6Forma y color:SolidPeso molecular:414.84PARP10-IN-2
CAS:<p>PARP10-IN-2 is a potent inhibitor of PARP10, a mono-ADP-ribosyltransferase, with an IC50 value of 3.64 μM for human PARP10.PARP10-IN-2 also inhibited PARP2 and</p>Fórmula:C14H10N2O2Pureza:99.27%Forma y color:SolidPeso molecular:238.24PCSK9-IN-13
CAS:PCSK9-IN-13 is a potent inhibitor of PCSK9, effectively preventing the binding of PCSK9 to low-density lipoprotein (LDL) receptors through its mechanism ofFórmula:C30H33N5O2Forma y color:SolidPeso molecular:495.62Vemtoberant
CAS:Vemtoberant is a β3 adrenergic antagonist used in β3-related disorder research like heart failure.Fórmula:C29H37N3O8S2Forma y color:SolidPeso molecular:619.75BDP5290
CAS:BDP5290 is a potent inhibitor of both ROCK and MRCK(IC50s of 5 nM, 50 nM, 10 nM and 100 nM for ROCK1, ROCK2, MRCKα and MRCKβ, respectively.)Fórmula:C17H18ClN7OPureza:97.22%Forma y color:SolidPeso molecular:371.82HSP90-IN-20
CAS:HSP90-IN-20, a potent inhibitor of HSP90, exhibits an IC50 of ≤10 μM, indicating its potential application in cancer research.Fórmula:C26H32N4O4Forma y color:SolidPeso molecular:464.56NLRP3-IN-14
CAS:NLRP3-IN-14, potent selective NLRP3 inhibitor, KD 5.87μM; IC50 0.131μM for IL-1β; for inflammation research.Fórmula:C27H28N2O4Forma y color:SolidPeso molecular:444.52NLRP3-IN-15
CAS:NLRP3-IN-15: potent, selective NLRP3 inflammasome inhibitor; IC50 0.114 μM for IL-1β; for inflammation research.Fórmula:C22H19NO4Forma y color:SolidPeso molecular:361.39NLRP3-IN-16
CAS:NLRP3-IN-16: potent NLRP3 inflammasome inhibitor; IC50=0.065μM; curbs IL-1β; used in inflammation studies.Fórmula:C25H25NO5Pureza:98%Forma y color:SolidPeso molecular:419.47THRX-144644
CAS:THRX-144644: lung-specific ALK5 inhibitor, 0.14 nM IC50, no systemic TGFβ toxicity.Fórmula:C26H28ClF2N7Forma y color:SolidPeso molecular:512ONO-0740556
CAS:ONO-0740556 is a potent agonist of the Gi-coupled human lysophosphatidic acid receptor 1 (LPA1), exhibiting an EC50 value of 0.26 nM.Fórmula:C20H34NO6PForma y color:SolidPeso molecular:415.46NLRP3-IN-13
CAS:<p>NLRP3-IN-13 is an NLRP3 inhibitor that inhibits NLRP3-associated inflammation.NLRP3-IN-13 can be used in the study of neurological disorders and inflammation.</p>Fórmula:C19H15N3O3SPureza:99.16%Forma y color:SolidPeso molecular:365.41MALT1-IN-11
CAS:<p>MALT1-IN-11: MALT1 inhibitor, IC50 <10-100 nM, reduces IL10, for cancer/autoimmune research.</p>Fórmula:C20H16F4N8OForma y color:SolidPeso molecular:460.39CU-CPT9b
CAS:<p>CU-CPT9b (TLR8-specific antagonist 1) is an antagonist of toll-like receptor 8 (TLR8; Kd = 21 nM).</p>Fórmula:C16H13NO2Pureza:98.1%Forma y color:SolidPeso molecular:251.28c-Met-IN-14
CAS:c-Met-IN-14: selective c-Met kinase inhibitor, IC50 2.89 nM, anticancer, stops G2/M phase, induces A549 cell apoptosis.Fórmula:C34H38ClFN4O7SForma y color:SolidPeso molecular:701.2PARP1-IN-12
PARP1-IN-12: potent PARP1 inhibitor, IC50 2.99 nM, triggers cell apoptosis, G2/M arrest, induces DSBs in BRCA-deficient cells.Fórmula:C43H56FN5O5Forma y color:SolidPeso molecular:741.93PARP7-IN-12
CAS:PARP7-IN-12, a potent inhibitor targeting PARP7, exhibits an IC50 of 7.836 nM. This compound is applicable in cancer research.Fórmula:C23H27ClF3N5O5Forma y color:SolidPeso molecular:545.94PARP-2-IN-3
CAS:<p>PARP-2-IN-3 is used in the study of breast cancer as a PARP-2 inhibitor with antitumor activity that induces apoptosis (apoptosis) and necrosis in cancer cells.</p>Fórmula:C20H20ClN3O3Pureza:99.33%Forma y color:SolidPeso molecular:385.84hCAIX-IN-16
CAS:hCAIX-IN-16 (Compound 12d), an inhibitor of hCA IX, exhibits inhibition constants (K i) of 190.0 nM for hCA IX and 187.9 nM for hCA XII.Fórmula:C20H20N8O2SPureza:98%Forma y color:SolidPeso molecular:436.49hCAIX-IN-15
CAS:hCAIX-IN-15 is a potent inhibitor of human carbonic anhydrase IX (hCA IX) with an inhibition constant (Ki) of 38.8 nM, exhibiting broad-spectrum anticancerFórmula:C18H14FN7O2SPureza:98%Forma y color:SolidPeso molecular:411.41LIXIVAPTAN
CAS:Lixivaptan (VPA-985) is an orally active and selective vasopressin receptor V2 antagonist(Ki = 2.3 nM)Fórmula:C27H21ClFN3O2Pureza:98.36%Forma y color:SolidPeso molecular:473.93hCAIX-IN-14
CAS:hCAIX-IN-14 is a potent inhibitor of human CA IX with a K i value of 134.8 nM .Fórmula:C11H17ClN6O2SForma y color:SolidPeso molecular:332.81HDAC6-IN-14
HDAC6-IN-14, an inhibitor of HDAC6 (HDAC), exhibits high selectivity with an IC50 value of 42 nM, demonstrating over 100-fold selectivity compared to HDAC1,Fórmula:C24H30FN3O4Forma y color:SolidPeso molecular:443.51
